A novel insulin analog with unique properties: [Lys.sup.B3], [Glu.sup.B29] insulin induces prominent activation of insulin receptor substrate 2, but marginal phosphorylation of insulin receptor substrate 1
The potentially enhanced mitogenic activity of insulin analogs represents a safety risk that requires detailed analysis of new analogs considered for therapeutic applications. We assessed the signaling properties and mitogenic potency of two novel rapid-acting insulin analogs, [Lys.sup.B3],[Glu.sup....
Gespeichert in:
Veröffentlicht in: | Diabetes (New York, N.Y.) N.Y.), 2003-09, Vol.52 (9), p.2227 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!